The complainant was unable to provide the upn and lot number.Therefore, the manufacture and expiration dates are unknown.According to the complainant, the suspect device is not available for return.If any further relevant information is received, a supplemental mdr will be filed.
|
It was reported to boston scientific corporation that a 20mm cre dilatation balloon was used on (b)(6) 2018 as part of the e7116 axios won drainage ide clinical trial.On (b)(6) 2018, the patient was enrolled to the study procedure.The patient had a medical history of severe acute necrotizing pancreatitis.The won (walled off necrosis) was located in the intrapancreatic.Mri indicated a 57% necrosis and on imaging the won was 14cm.It was reported that the patient began hospitalization on (b)(6) 2018.On (b)(6) 2018, the patient underwent an axios stent placement procedure transgastric to the won.Antibiotic therapy was given.Won characteristics were as follows: long axis was 14cm, short axis was 10cm, % necrotic material was 80%, and wall characteristic was soft.The axios stent was placed in the desired location without issue and a 20mm cre dilation balloon was used to dilate the stent.Necrotic drainage was visualized through the axios stent from the stomach or bowel.Bleeding occurred due to dilation with a 20mm cre dilatation balloon, though no malfunction or deficiency of the balloon was reported.It was noted that the patient had very low albumin level and that the bleeding was most likely from a small vessel just behind the balloon inside of the won.Tamponade of the bleed with the balloon was attempted but was not effective.Endoscopic suturing was then performed which immediately stopped the bleeding.It was reported that the patient is doing well.
|